Literature DB >> 2476383

Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release.

M V White1, T Yoshimura, W Hook, M A Kaliner, E J Leonard.   

Abstract

Basophils from five of six human donors released histamine in response to neutrophil attractant/activation protein-1 (NAP-1). Histamine release by this protein was concentration-dependent over the range of 3 x 10(-7) M to 4 x 10(-6) M. At 4 x 10(-6) M, the mean agonist-induced release was 16 +/- 3% (SEM) of total basophil histamine. For the same basophil preparations, release by anti-IgE was 35 +/- 6%. The chemotactic protein did not cause release of histamine from basophils at 0 degrees C or in the presence of 10 mM EDTA. The time-course of histamine release was rapid; release was 43% of maximal after 30 s and maximal after 1 min of incubation. Thus, in addition to its previously characterized neutrophil chemotactic and activating properties, this protein activates human basophils.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476383     DOI: 10.1016/0165-2478(89)90182-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  19 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Transcriptional activation of the interleukin-8 gene by platelet-activating factor in human peripheral blood monocytes.

Authors:  S Denault; M J April; J Stanková
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

3.  The role of CD18 in IL-8 induced dermal and synovial inflammation.

Authors:  M J Forrest; G J Eiermann; R Meurer; L A Walakovits; D E MacIntyre
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

4.  Molecular analysis of the inhibition of interleukin-8 production by dexamethasone in a human fibrosarcoma cell line.

Authors:  N Mukaida; G L Gussella; T Kasahara; Y Ko; C O Zachariae; T Kawai; K Matsushima
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

Review 5.  IgE-dependent histamine-releasing factors.

Authors:  H A Sampson; S M MacDonald
Journal:  Springer Semin Immunopathol       Date:  1993

6.  HRF of 30 kDa: evidence for active synthesis.

Authors:  C Brunet; J Hébert
Journal:  Agents Actions       Date:  1993-07

7.  Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.

Authors:  P Roux; C Alfieri; M Hrimech; E A Cohen; J E Tanner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.

Authors:  M L Baeza; S R Reddigari; D Kornfeld; N Ramani; E M Smith; P A Hossler; T Fischer; C W Castor; P G Gorevic; A P Kaplan
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

9.  Characterization of histamine-releasing activity: role of cytokines and IgE heterogeneity.

Authors:  T N Liao; K H Hsieh
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

10.  Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC.

Authors:  Bartosz Bielecki; Andzelika Mazurek; Paweł Wolinski; Andrzej Glabinski
Journal:  J Clin Immunol       Date:  2007-10-25       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.